Royalty Pharma plc EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 78.09%

Royalty Pharma plc EBT Margin is 78.09% for the Trailing 12 Months (TTM) ending March 31, 2025, a 47.25% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Royalty Pharma plc EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 53.03%, a 104.74% change year over year.
  • Royalty Pharma plc EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 25.90%, a -51.24% change year over year.
  • Royalty Pharma plc EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 53.12%, a -33.48% change year over year.
  • Royalty Pharma plc EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 79.85%, a -30.95% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin